10th workshop on Innovative Models
- Start date:
- 19 June 2019
- 3 days
- Working as:
- Resident physician, Medical specialist, PhD
On 19-21 June 2019, the Netherlands Cancer Institute and the Leiden University Medical Center organize the 10th edition of the workshop on Innovative Mouse Models (IMM2019) in Leiden, the Netherlands.
- How to make genetically-engineered mice in the CRISPR/Cas9 era?
- Novel in vivo applications of CRISPR/Cas9 technology
- Advanced imaging and phenotyping
- How to deal with the mouse microbiota?
- Closing debate: the future of mouse models in fundamental and/or translational research
The goal of IMM2019 is to bring together a diverse group of scientists interested in all aspects of advanced mouse experiments within current ethical standards. Among the participants are key developers of emerging technologies as well as researchers who wish to apply and assess these new approaches. The workshop encourages an in-depth and unvarnished discussion of novel developments in a 3-day program with a series of invited speakers and presentations selected from submitted abstracts. IMM2019 is a unique opportunity for young researchers to share their experiences by means of a poster or brief oral presentation with a highly specialized audience.
If you want to submit an abstract please go to the abstract site.
Resident physician, Medical specialist, Phd students, post-docs, technician, group leaders, members of research facilities
By registering you agree that your name, organization, city and e-mail address will be available to the workshop participants for a fruitful communication.
For the latest program and speakers, please visit the IMM2019 website.
LUMCAlbinusdreef 2, Leiden
Building: Gebouw 1
€200,- early fee (until 26 April 2019)
€250,- late fee (from 27 April 2019)
€170,- early fee ISTT Member (until 26 April 2019)
€220,- late fee ISTT Member (from 27 April 2019)
Registration will be closed on May 19, 2019.
Dietary Wishes: If you click on the check mark of dietary wishes. We will contact you through email.